GIA
CLDX icon

GHP Investment Advisors’s Celldex Therapeutics CLDX Stock Holding History

GHP Investment Advisors’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$793 Hold
25
– – ﹤0.01% 1062
2025
Q4 		$679 Buy
+25
New +$658 ﹤0.01% 931
2023
Q2 		– Sell
-4
Closed -$144 – 932
2023
Q1 		$144 Hold
4
– – ﹤0.01% 905
2022
Q4 		$178 Hold
4
– – ﹤0.01% 910
2022
Q3 		$0 Hold
4
– – ﹤0.01% 906
2022
Q2 		$0 Hold
4
– – ﹤0.01% 942
2022
Q1 		$0 Buy
+4
New +$128 ﹤0.01% 938

Other funds holding CLDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return